AVCJ

AVCJ Awards 2019 - Voting has closed

  • Staff writer
  • LinkedIn  
  • Google plus  
  • Save this article  

Voting for the 2019 AVCJ Private Equity & Venture Capital Awards has now closed. Many thanks for your participation. The winners will be announced on November 11.

To review the nominee shortlists and cast your vote, please go to the AVCJ Awards website (https://www.avcjforum.com/awards), which also includes full details of the process. 

The region's PE and VC community has a 50% say in the result, with the judges and the AVCJ Editorial Board accounting for 40% and 10% respectively. As in previous years, voting is not limited to AVCJ subscribers but participants must register - providing name, company and contact details - so as to avoid vote packing. No more than 10 votes will be accepted from employees of a single firm. 

Three categories are not subject to a public vote. The Operational Value Add Award and the Responsible Investment Award are presented at the discretion of the AVCJ Editorial Board with substantial input from separate judging panels of industry professionals with expertise in those fields. Meanwhile, the AVCJ Special Achievement Award is presented solely at the discretion of the AVCJ Editorial Board. 

Relying in part on industry recommendations, the AVCJ Editorial Board drew up nominee shortlists in consultation with the judging panel.

The nominees in each category are as follows:

Fundraising of the Year – Venture Capital 

  • A91 Partners Fund I (A91 Partners)
  • GGV Capital VII (GGV Capital)
  • Globis Fund VI (Globis Capital Partners)
  • Joy Capital III & Joy Capital Opportunity (Joy Capital)
  • LAV Biosciences Fund V (Lilly Asia Ventures) 

Fundraising of the Year – Mid Cap

(Fund size - below $2 billion)

  • C-Bridge Healthcare Fund III (CBC Group)
  • ChrysCapital VIII (ChrysCapital Partners)
  • Genesis Capital II (Genesis Capital)
  • Mercury Capital Fund 3 (Mercury Capital)
  • Quadrant Growth Fund (Quadrant Private Equity) 

Fundraising of the Year – Large Cap

(Fund size - $2 billion and above) 

  • Bain Capital Asia Fund IV (Bain Capital)
  • Centurium Capital Partners 2018 (Centurium Capital)
  • CITIC Capital China Partners IV (CITIC Capital)
  • DCP Capital Partners I (DCP Capital)
  • PAG Asia III (PAG Asia Capital) 

Deal of the Year – Small Cap

(Equity commitment – below $50 million) 

  • AffaMed Therapeutics (CBC Group)
  • Bowtie Life Insurance (Hong Kong X-Tech Startup Platform/Sun Life Hong Kong)
  • Insilico Medicine (Baidu Ventures/Bold Capital Partners/Eight Roads/F-Prime Capital/Lilly Asia Ventures/Pavilion Capital/Qiming Venture Partners/Sinovation Ventures)
  • Mswipe Technologies (B Capital Group/DSG Consumer Partners/Epiq Capital/Falcon Edge Capital)
  • Yunhu Health (BioTrack Capital/Cash Capital/ China Creation Ventures/ZWC Ventures) 

Deal of the Year – Mid Cap

(Equity commitment – $50-199 million) 

  • Chindata (Bain Capital)
  • Hangzhou UCO Cosmetics (CITIC Capital)
  • Market Kurly (Capstone Partners/DST Global/Global Venture Partners/Hillhouse Capital/Korea Investment Partners/Mirae Asset Venture/Sequoia Capital China/Translink Capital/UTC Investment)
  • Orion Breweries (The Carlyle Group/Nomura Capital Partners)
  • Zenitas Healthcare (Adamantem Capital/Liverpool Partners) 

Deal of the Year – Large Cap

(Equity commitment – $200 million and above) 

  • Amer Sports (FountainVest Partners)
  • Baosteel Gases (PAG Asia Capital)
  • ByteDance Technology (General Atlantic/KKR/Primavera Capital Group/SoftBank)
  • Scottish Pacific (Affinity Equity Partners)
  • SK Shipping (Hahn & Company) 

Exit of the Year – IPO

(Please see awards website for list of investors) 

  • Innovent Biologics
  • Luckin Coffee
  • Sansan
  • Tencent Music Entertainment Group
  • Whispir 

Exit of the Year – Small Cap

(Equity commitment on entry – below $50 million) 

  • EuroKids International (Gaja Capital)
  • Samyang Optics (VIG Partners)
  • Manjushree Technopack (Kedaara Capital)
  • Star Health & Allied Insurance (Apis Partners/ICICI Venture/Tata Capital Growth Fund)
  • Gong Cha Korea (Unison Capital) 

Exit of the Year – Mid Cap

(Equity commitment on entry – $50-149 million) 

  • Ayumi Pharmaceuticals (Unison Capital)
  • Geo-Young (Anchor Equity Partners)
  • Manuka Health (Pacific Equity Partners)
  • MAP Aktif Adiperkasa (CVC Capital Partners)
  • Nippon Outsourcing Corporation (The Longreach Group) 

Exit of the Year – Large Cap

(Equity commitment on entry – $150 million and above) 

  • Allied Pinnacle (Pacific Equity Partners)
  • Hitowa Holdings (CVC Capital Partners)
  • KCF Technologies (KKR)
  • MYOB (Bain Capital)
  • United Family Healthcare (Fosun Group/TPG Capital) 

Firm of the Year – Mid Cap

(AUM – below $5 billion) 

  • Centurium Capital
  • ChrysCapital Partners
  • Joy Capital
  • Lilly Asia Ventures
  • Openspace Ventures 

Firm of the Year – Large Cap

(AUM - $5 billion and above) 

  • CITIC Capital
  • KKR
  • Pacific Equity Partners
  • PAG Asia Capital
  • Warburg Pincus
  • LinkedIn  
  • Google plus  
  • Save this article  

More on Performance

Latest News

Asian GPs slow implementation of ESG policies - survey
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs